Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets, thrombosis and atherosclerosis

J F Mustard, S Moore, M A Packham

    Progress in Biochemical Pharmacology
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Characteristics, Origins, and Biosignature Preservation Potential of Carbonate-Bearing Rocks Within and Outside of Jezero Crater.

    Journal of geophysical research. Planets·2021
    Same author

    Earth-like Habitable Environments in the Subsurface of Mars.

    Astrobiology·2021
    Same author

    Changes in Phosphoinositides in Rabbit Platelets during Clot Formation. Comparison of Platelets Stimulated by ADP or by Thrombin in the Presence of Polymerising Fibrin.

    Platelets·2010
    Same author

    Ontario's Mustard Report: Its Implications For Family Physicians.

    Canadian family physician Medecin de famille canadien·2010
    Same author

    Closing remarks / conclusion.

    Canadian Medical Association journal·2010
    Same author

    Acute Myocardial Infarction in the Presence of Thrombocytopenia.

    Canadian Medical Association journal·2010
    Same journal

    Dietary fiber research.

    Progress in biochemical pharmacology·1990
    Same journal

    Biologically active ether lipids.

    Progress in biochemical pharmacology·1988
    Same journal

    Effect of changes in intracellular pH on the contractility of rat resistance vessels.

    Progress in biochemical pharmacology·1988
    Same journal

    Vasoreactive effects of hypothalamic sodium transport inhibitor.

    Progress in biochemical pharmacology·1988
    Same journal

    Platelet-activating factor and the cardiovascular system: involvement in cardiac anaphylaxis.

    Progress in biochemical pharmacology·1988
    Same journal

    Synthesis of biologically active ether lipids.

    Progress in biochemical pharmacology·1988
    See all related articles

    Platelet interactions with vessel walls contribute to atherosclerosis development and complications. Drugs inhibiting platelet function may help manage atherosclerosis by reducing blood clot formation and vessel injury responses.

    Area of Science:

    • Cardiovascular Science
    • Hematology
    • Pathology

    Background:

    • Platelet interaction with the vessel wall is implicated in early atherosclerosis.
    • Platelets contribute to thrombus formation following vessel injury, potentially causing clinical complications.
    • Repeated emboli formation from mural thrombi can exacerbate atherosclerotic complications.

    Purpose of the Study:

    • To explore the role of platelet-vessel wall interactions in atherosclerosis.
    • To investigate the potential of antiplatelet drugs in managing atherosclerosis and its complications.

    Main Methods:

    • Review of literature on platelet function and atherosclerosis.
    • Analysis of the effects of platelet inhibition on vascular responses.

    Related Experiment Videos

    Main Results:

    • Platelet interactions influence smooth muscle cell proliferation and endothelial permeability.
    • Platelet emboli contribute to the clinical manifestations of atherosclerosis.
    • Drugs like sulfinpyrazone and dipyridamole show potential in mitigating vascular injury responses.

    Conclusions:

    • Modulating platelet function is a potential therapeutic strategy for atherosclerosis.
    • Inhibiting platelet response to vessel injury may reduce atherosclerotic complications.